Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amedisys, Inc. (NASDAQ:AMED – Free Report) – Stock analysts at William Blair reduced their Q2 2023 earnings per share estimates for shares of Amedisys in a report issued on Tuesday, June 27th. William Blair analyst M. Larew now anticipates that the health services provider will post earnings per share of $1.02 for the quarter, down […]
Benchmark cut shares of Amedisys (NASDAQ:AMED – Free Report) from a buy rating to a hold rating in a report issued on Tuesday morning, The Fly reports. AMED has been the topic of several other reports. Cantor Fitzgerald upped their price target on shares of Amedisys from $91.00 to $100.00 in a report on Tuesday, […]
Amedisys (NASDAQ:AMED – Free Report) had its price objective upped by Truist Financial from $97.00 to $101.00 in a research note published on Tuesday, The Fly reports. AMED has been the topic of a number of other research reports. Stephens reissued an equal weight rating and issued a $103.00 target price on shares of Amedisys […]
StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report report published on Sunday morning. The firm issued a buy rating on the health services provider’s stock. Several other brokerages also recently commented on AMED. SVB Securities dropped their price target on Amedisys from $96.00 to $81.00 in a research […]
Research analysts at StockNews.com initiated coverage on shares of Amedisys (NASDAQ:AMED – Get Rating) in a report released on Sunday. The brokerage set a “buy” rating on the health services provider’s stock. AMED has been the topic of a number of other research reports. Benchmark reissued a “buy” rating and issued a $115.00 price target […]